secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001193125-24-049499
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics enters $50M ATM with TD Cowen; reports preliminary cash of $9.4M
--------------------------------------------------------------------------------

- Entered Sales Agreement with TD Cowen for at-the-market offering of up to $50M of Class A common stock at 3% commission.
- Preliminary cash and cash equivalents ~$9.4M as of Dec 31, 2023, subject to completion of financial closing and audit.
- Terminated prior ATM program with Cantor Fitzgerald on Feb 26, 2024.
- Company is not obligated to sell any shares; offering is under existing effective S-3 shelf registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000119312524049499/0001193125-24-049499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000119312524049499/d766950d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-049499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer